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The Th2 locus control region (LCR) has been shown to be important
in efficient and coordinated cytokine gene regulation during Th2
cell differentiation. However, the molecular mechanism for this is
poorly understood. To study the molecular mechanism of the Th2
LCR, we searched for proteins binding to it. We discovered that
transcription factor YY1 bound to the LCR and the entire Th2 cyto-
kine locus in a Th2-specific manner. Retroviral overexpression of
YY1 induced Th2 cytokine expression. CD4-specific knockdown of
YY1 in mice caused marked reduction in Th2 cytokine expression,
repressed chromatin remodeling, decreased intrachromosomal in-
teractions, and resistance in an animal model of asthma. YY1 phys-
ically associated with GATA-binding protein-3 (GATA3) and is
required for GATA3 binding to the locus. YY1 bound to the regu-
latory elements in the locus before GATA3 binding. Thus, YY1 coop-
erates with GATA3 and is required for regulation of the Th2
cytokine locus and Th2 cell differentiation.
Th2 cytokine genes il4, il13, and il5 are clustered in chromosome5 in human and chromosome 11 in mouse. The expression of
the Th2 cytokine genes are coordinately regulated during Th2 cell
differentiation. Several different regulatory elements have been
shown to play an important role in Th2 cytokine gene expression,
including promoters of Th2 cytokine genes, enhancers [conserved
noncoding sequence 1 (CNS1)/hypersensitive site 1-3 (HSS1-3),
hypersensitive site V (HSV)/CNS2, and intronic enhancer (IE)/
HSII], a silencer (HSIV), and a locus control region (LCR) (1, 2).
The functions of these regulatory elements in Th2 cytokine ex-
pression in Th2 cells in vivo have been thoroughly investigated in
transgenic mice and knockout mice that have targeted deletion in
the regulatory elements (3–10). Among these regulatory elements,
Th2 LCR has been shown to coordinately regulate Th2 cytokine
genes, to induce chromatin remodeling, and to be required for
chromosomal interactions (1, 2). The Th2 LCR is located in the
introns of the Rad50 gene and is composed of four DNase I hy-
persensitive sites, including RHS4, RHS5, RHS6, and RHS7 (11,
12). In previous studies, we have shown that theTh2LCR is essential
for Th2 cytokine expression and chromosome remodeling in theTh2
cytokine locus and in the pathogenesis of allergic asthma (7, 11, 13).
The entire Th2 cytokine locus undergoes chromatin remodeling
during Th2 cell differentiation (1, 2, 14). DNase I hypersensitive
sites, which reflect accessibility of chromatin, are developed at the
specific regulatory regions during Th2 cell differentiation (15, 16).
Histone 3 lysine 9 (H3K9)-acetylation and histone 3 lysine 4
(H3K4)-methylation increase at specific regulatory regions in the
Th2 cytokine locus during Th2 cell differentiation (17–20). Th2
cytokine locus also undergoes DNA demethylation during Th2
cell differentiation (11, 21–26). Treatment with drugs that cause
chromatin modification such as 5-azacytidine or Trichostatin A
induces Th2 cytokine expression upon T-cell receptor (TCR)
stimulation without IL-4 (27). In addition, deficiency in chroma-
tin-modifying enzymes in CD4 T cells causes aberrant cytokine
expression (28–30). These results suggest that chromatin mod-
ifications are critically important for Th2 cytokine expression and
Th2 differentiation. GATA3, the key transcription factor for Th2
differentiation (31), can induce chromatin remodeling at the Th2
cytokine locus without IL-4 signaling (32–34), suggesting that it
plays a major role in the chromatin remodeling process. However,
how GATA3 induces chromatin remodeling during Th2 cell dif-
ferentiation is poorly understood.
The Th2 cytokine locus also engages in chromosomal inter-
actions by either intra- or interchromosomal association (35–38).
The Th2 LCR interacts with the promoters of Th2 cytokine genes
and enhancers through long-range intrachromosomal interactions
(35). Ectopic expression of gata3 with the treatment of phorbol
myristate acetate (PMA) + ionomycin is sufficient to induce some
of intrachromosomal interactions in fibroblast cells (35), suggest-
ing that GATA3 plays an important role in this process. Intra-
chromosomal interactions in the Th2 cytokine locus are greatly
reduced in RHS7-deficient cells (7), suggesting that RHS7 is crit-
ical in chromosomal interactions. The Shigematsu group has
shown that SATB1-binding sites present in the Th2 cytokine locus
undergo long-range intrachromosomal interaction in fully de-
veloped Th2 cells (D10 cells), and that SATB1 plays a critical role
in these interactions (36). The Th2 cytokine locus also interacts
with the IFN-γ gene locus, which is present in a different chro-
mosome, as a result of interchromosomal interaction (37).
Although the regulatory elements in the Th2 cytokine locus and
the chromatin remodeling are well understood, the underlying mo-
lecular mechanism of chromatin remodeling and chromosomal in-
teraction—in particular, which proteins play a role in this process—
has not been adequately determined. To examine the molecular
mechanism in the function of the Th2LCR,we searched for proteins
binding to RHS7 using a transcription factor-binding database and
an EMSA and discovered YY1 as a candidate binding protein. YY1
bound to several regulatory elements in the Th2 cytokine locus, in-
cluding RHS7. Overexpression of YY1 induced the expression of
Th2 cytokine genes. Th2 cells from CD4-sppecific YY1 knockdown
(KD) mice showed a reduction in Th2 cytokine expression, inactive
chromatin conformation, and intrachromosomal interactions, and
resistance in an animal model of asthma. YY1 interacted with
GATA3, and YY1 was required for binding of GATA3 to the Th2
cytokine locus. These results strongly suggest that YY1 is a critical
transcription factor mediating Th2 cytokine locus regulation in co-
operation with GATA3.
Results
YY1 Bound to RHS7 and Other Regulatory Elements in the Th2 Cytokine
Locus. To examine the molecular mechanism of the Th2 LCR, we
searched for proteins that bind to RHS7. Using a DNA sequence
comparison between human and mouse, the Promo program,
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which is based on the TRANSFAC 8.3 database (http://alggen.lsi.
upc.es), and an EMSA, we discovered that a transcription factor
YY1 can bind to a short region of RHS7, which we named as
RHS7b, in a Th2-specific manner (Fig. S1 A and B). Specific
binding of YY1 to RHS7b was confirmed by antibody-supershift
and oligonucleotide competition assays (Fig. S1C).
To examine whether YY1 binds to other regulatory elements in
the Th2 cytokine locus in vivo, we performed a ChIP assay (Fig.
1A). Fragmented chromatin from Th1 or Th2 cells was pre-
cipitated with an anti-YY1 antibody, and the relative amount of
precipitatedDNAwasmeasured by quantitative PCR. YY1 bound
to several regulatory elements in the Th2 cytokine locus, including
the promoters of IL-4 and IL-13 genes, RHS7, CNS1/HSS, HSV/
CNS2, HSIV, and HSVa in a Th2-specific manner (Fig. 1A).
Next, we examined whether YY1 is induced by Th1 or Th2 stim-
ulation. Naive CD4 T cells from C57BL/6 were stimulated under ei-
ther a Th1 or Th2 polarizing condition. The amount of yy1 transcript
and YY1 protein was analyzed by quantitative RT-PCR and immu-
noblot analysis, respectively. YY1was rapidly induced as early as 12 h
after TCR stimulation both in Th1 and Th2 cells, but to a greater
extent inTh2 cells at both theRNAandprotein level (Fig. 1B andC).
Ectopic Expression of yy1-Induced Th2 Cytokine Expression. To ex-
plore the role of YY1 in Th2 cytokine gene expression, we used
ectopic expression of yy1 withMIEG3 retroviral vector. The vector
contains an internal ribosomal entry site, so it coexpresses a GFP in
the transduced cells.We transduced yy1 into naive CD4 T cells and
differentiated toward Th1 or Th2. The expression of Th1 and Th2
cytokines was measured by intracellular cytokine staining and by
quantitative RT-PCR with sorted GFP+ cells (Fig. S2). Ectopic
expression of yy1 modestly induced all Th2 cytokines, IL-4, IL-5,
and IL-13 in Th2 cells. However, YY1 did not affect the expression
of ifng in Th1 cells. Next, we performed the same retroviral trans-
duction experiment with RHS7-deficient mice to examine whether
RHS7 is required for the function of YY1 (Fig. S2). Although the
induction of Th2 cytokines by YY1 was not affected, the amount of
Th2 cytokines expressed greatly reduced in RHS7 KO Th2 cells
compared with that in WT Th2 cells (Fig. S2), suggesting that ex-
pression of Th2 cytokines by YY1 requires RHS7.
YY1 KD Reduced Th2 Cytokine Expression. To investigate the func-
tion of YY1 in physiological conditions, we used conditional YY1
KD mice (39). This mouse contains pSico-YY1 as a transgene, in
which split U6 promoters can be joined together by removing in-
tervening CMV-EGFP by Cre/loxP recombination (39). pSico-
YY1 transgenic mice were crossed with CD4-Cre transgenic mice
to generate pSico-YY1(CD4-Cre) mice (YY1 KDmice) that have
YY1 KD in CD4 T cells. We first examined the expression of YY1
in CD4 T cells from pSico-YY1(CD4-Cre) mice. The amount of
YY1 protein was almost completely reduced in CD4 T cells from
pSico-YY1(CD4-Cre) mice compared with those from pSico-YY1
control mice (Fig. 2A). We also examined whether conditional
YY1KD inCD4T cells has any developmental defect. The ratio of
CD4 single positive to CD8 single positive T cells in the thymus was
normal in pSico-YY1(CD4-Cre) mice (Fig. S3A). However, the
ratios of CD4 to CD8 cells and of T to B cells were reduced by half
compared with those of control pSico-YY1mice in the spleen (Fig.
S3B andC). The ratio of naive to effector/memoryCD4T cells was
no different in pSico-YY1(CD4-Cre)mice from that in pSico-YY1
mice (Fig. S3D). The proliferation of splenic naive CD4 T cells
frompSico-YY1(CD4-Cre)micewas comparable to that in control
mice (Fig. S3E). These results suggest that, although there is
a partial reduction in the ratio of CD4 T-cell population in the
periphery of the pSiro-YY1(CD4-Cre) mice, peripheral CD4 T
cells from these mice do not have notable functional defects in
activation and proliferation. Therefore, we determined to use
these mice for further experiments.
To investigate the functional role of YY1 in Th2 cell differen-
tiation, we examined the Th1/Th2 cytokine expression in pSico-
YY1(CD4-Cre) mice. Naive CD4 T cells were isolated from the
spleen of pSico-YY1(CD4-Cre) and control pSico-YY1 mice and
differentiated into a Th1 or Th2 polarizing condition. The ex-
pression of cytokine genes was measured at the transcriptional
level by quantitative RT-PCR. Interestingly, the expression of il4
was found to be greatly reduced in pSico-YY1(CD4-Cre) cells
compared with control cells, and that of il5 and il13 was also re-
duced by half compared with those in control cells (Fig. 2B).
However, the expression of ifng was no different between pSico-
YY1(CD4-Cre) cells and control cells. The same result was
obtained at the protein level, measured by ELISA (Fig. 2C). We
also measured the expression of subset-specific transcription fac-
tors T-bet, GATA3, and STAT6 in these cells. The expression of
these factors was no different betweenYY1KDand control cells at
the protein and transcript levels (Fig. 2 A and B), suggesting that
the reduction of Th2 cytokines in YY1 KD Th2 cells is not due to
altered expression of these transcription factors.
YY1 KD Reduced Chromatin Remodeling in the Th2 Cytokine Locus. To
investigate whether YY1 plays a role in chromatin remodeling in
the Th2 cytokine locus, we measured H3K4-methylation and H3-
acetylation states, which are activation markers, using ChIP.
Both H3K4-methylation and H3-acetylation were reduced in
many regulatory elements in the Th2 cytokine locus, including
the promoters of the Th2 cytokine genes, enhancers, and a locus
control region in YY1 KD Th2 cells, compared with control cells
(Fig. S4 A and B). We also measured DNA methylation at the
il4 promoter and RHS7 in Th2 cells from WT and YY1 KD
mice. DNA methylation at sites between –501 and –274 from the
il4 transcriptional start site and the entire region of RHS7 sub-
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Fig. 1. YY1 binding to Th2 cytokine locus and its expression. (A) YY1
binding to the Th2 cytokine locus in a Th2-specific manner. YY1 binding to
regulatory regions at the Th2 cytokine locus in Th1 and Th2 cells was mea-
sured by ChIP using an anti-YY1 antibody or control IgG. Data are shown as
percentages of input DNA. Error bar shows SD (n = 3). Data are represen-
tative of two independent experiments with similar results. (B and C) Th2-
specific expression of YY1. Expression of YY1 was measured by quantitative
RT-PCR at various time points after stimulation (B) or by immunoblotting at
day 4 (C) in Th1 and Th2 cells. Error bar shows SD (n = 3). Statistical differ-
ence between YY1 Th1 and YY1 Th2 or between YY1 Th2 and control Th2
was analyzed by Student t test. *P < 0.05.














































control Th2 cells (Fig. S4C). Taken together, these results sug-
gest that YY1 is required for permissive chromatin state for gene
activation in the Th2 cytokine locus.
YY1 Is Required for Long-Range Chromosomal Interactions in the Th2
Cytokine Locus. The regulatory elements for Th2 cytokine gene ex-
pression have been shown to interact with the promoters of the Th2
cytokine genes through long-range chromosomal interactions (35,
36). To examine the role of YY1 in long-range chromosomal inter-
actions, we measured the interactions of the il4 promoter with other
regulatory elements at the Th2 cytokine locus in Th1 and Th2 cells
from YY1 KD and control mice using a chromosome conformation
capture assay. Both Th1 and Th2 cells from control mice showed
high frequencies of interactions between the il4 promoter and other
promoters and regulatory elements, including the il5 promoter, il13
promoter, CNS1, RHS4-5, and RHS7, confirming poised chromo-
somal interactions in the Th2 cytokine locus (35). Interestingly, these
long-range chromosomal interactions were reduced by about half in
YY1 KD Th2 cells compared with those in control Th2 cells (Fig.
S5). This result suggests thatYY1 is required for full function of long-
range chromosomal interactions in the Th2 cytokine locus.
GATA3 Binding to Regulatory Elements in Th2 Cytokine Locus Requires
YY1. To explore the molecular mechanism of YY1 in Th2 cell
differentiation, we examined whether YY1 interacts with the key
Th2 transcription factor GATA3. To this end, we transfected the
expression vectors for yy1 and gata3 into 293T cells and performed
a coimmunoprecipitation assay using specific antibodies against
YY1 or GATA3. Our results showed that YY1 and GATA-3 were
coimmunoprecipitated in these cells (Fig. 3A), suggesting physical
association of these proteins.
We also examined the interactions of these proteins using im-
munofluorescence. Cellular localization of YY1 and GATA3 in in
vitro–differentiated Th1 or Th2 cells from C57BL/6 mice was ex-
amined using fluorescence-labeled anti-YY1 or anti-GATA3 anti-
bodies. YY1 and GATA3 were colocalized in the nucleus of Th2
cells but not in Th1 cells (Fig. 3B), suggesting Th2-specific associa-
tion of these proteins. Th2-specific association of YY1withGATA3
was further confirmed by an in situ proximity ligation assay that
detects interactions of proteins in cells and tissues (40) (Fig. 3C).
Next, we examined whether GATA3 binding to the Th2 cy-
tokine locus requires YY1, using ChIP in in vitro–differentiated
Th1 or Th2 cells from YY1 KD or control mice. GATA3 binding
to many regulatory elements in the Th2 cytokine locus, including
IL4P, IL5P, IL13P, RHS5, RHS6, RHS7, HSV/CNS2, CGRE,
IE/HSII, HSIV, and HSVa, increased in Th2 cells compared with
that in Th1 cells (Fig. 4A). By comparing the binding of YY1
(Fig. 1A), we found that some sites of the locus such as IL4P,
IL5P, IL13P, RHS7, CNS1, HSV/CNS2, HSII/IE, HSIV, and











































































































































































Fig. 2. Expression of transcriptions factors and cytokines in YY1 KD cells. (A) Expression of YY1 and other transcription factors in YY1 KD cells. Cell extracts
were prepared from in vitro–differentiated Th2 cells from control (pSico-YY1) or YY1 KD [pSico-YY1 (CD4-Cre)] mice. Protein expression was measured by
immunoblot analysis with specific antibodies for the transcriptions factors or β-actin as an internal control. The effect of YY1 KD on Th1-/Th2-specific gene
expression. Naive CD4 T cells were isolated from control (pSico-YY1) or YY1 KD [pSico-YY1(CD4-Cre)] mice, and differentiated under a Th1 or Th2 polarizing
condition. (B) Total RNA was isolated from the cells, and gene expression was measured by quantitative RT-PCR. y axis shows the relative expression amount
of each gene to the internal control hprt (encoding HPRT). Data are representative of three independent experiments with similar results. (C) Cytokines
secreted into the culture media were measured by ELISA. Statistical difference between control Th2 and YY1KD Th2 was analyzed by Student t test. n = 3.
*P < 0.05, **P < 0.01, ***P < 0.001. Data are representative of three independent experiments with similar results.






































such as RHS5, RHS6, and CGRE were bound by only GATA3.
Interestingly, the GATA3 binding to regulatory elements was
greatly reduced in YY1 KD Th2 cells (Fig. 4A). These results
suggest that GATA3 binding to regulatory elements requires
YY1. In contrast, YY1 binding to Th2 locus was not much dif-
ferent in WT and GATA3 KO cells (Fig. S6), suggesting that
YY1 binding to the locus does not require GATA3.
To gain insight into this process, we measured the kinetics of
YY1 and GATA3 binding in developing Th1 and Th2 cells. Naive
CD4 T cells were stimulated under a Th1 or Th2 polarizing con-
dition, and the binding of YY1 and GATA3 was measured with
ChIP at various time points. YY1 binding to at least some of the
regulatory elements, including the promoters of IL-4 and IL-5
genes, RHS7, CNS1, HSIV, and HSVa, increased at 12 h in Th2
cells (Fig. 4B), whereas GATA3 binding to these elements in-
creased at a later time point (at 24 h). These results suggest that
YY1 binding to some regulatory sites precedesGATA3 binding. In
contrast, the binding of YY1 to Th2 locus was very low at all times
in Th1 cells except RHS7, suggesting that Th2 specificity may be
due to differential binding of YY1 to Th2 locus (Fig. 4B). Taken
together with the data showing defective GATA3 binding in YY1
KDcells, these data suggest that YY1may recruitGATA3 in those
regulatory elements in Th2 cells.
YY1 Is Required but Not Sufficient for Th2 Cytokine Expression. To
examine the functional relationship betweenYY1 andGATA3, we
transduced the retroviral gata3 expression vector into YY1 KD
cells and transduced the retroviral yy1 expression vector into
GATA3fl/fl cells together with RV-Cre (conditional GATA3-de-
ficient cells) (Fig. 5). In the conditional GATA3-deficient cells,
exons of GATA3 gene flanked by loxp sites can be deleted by ret-
roviral expression of Cre recombinase. As was shown previously
(32–34), ectopic expression of gata3 induced il4 expression in
control Th1 cells (Fig. 5A). The expression of il4, il5, and il13
inYY1KDTh2 cells was substantially reduced comparedwith that
in YY1-sufficient control cells. When gata3 was ectopically ex-
pressed in YY1 KD Th1 or Th2 cells, il4 was induced to a level
comparable to control cells (Fig. 5). This result suggests that al-
though YY1 is required for the full expression of Th2 cytokine
genes, this necessity can be overcome by overexpression of gata3.
In contrast, ectopic expression of yy1 could not induce il4, il5, and
il13 in either Th1 or Th2 cells from conditional GATA3-deficient
mice (Fig. 5), suggesting that, unlikeGATA3,YY1 is necessary but
not sufficient to regulate Th2 cytokine expression.
YY1 Is Essential for Animal Model of Asthma. To investigate the role
of YY1 in Th2 cell function in vivo, we used an animal model of
allergic asthma. We sensitized and challenged control or YY1 KD
mice with ovalbumin (OVA) and examined airway inflammation in
the lung. Eosinophils and lymphocytes were recruited in bron-
choalveolar lavage fluid in OVA-challenged control mice, but
these cells were greatly reduced inOVA-challengedYY1KDmice
(Fig. S7A). Lung-infiltrating inflammatory cells were also greatly
reduced in these mice (Fig. S7B). In addition, the production of
mucus wasmodestly reduced in thesemice (Fig. S7C). The amount
of serum IgE (Fig. S7D) and the expression of Th2 cytokine and
chemokine genes (Fig. S8) were also greatly reduced in OVA-
challenged YY1 KD mice compared with those in OVA-chal-
lenged control mice. These results suggest that YY1 is essential for
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Fig. 3. Interactions between YY1 and GATA3. (A) 293T cells were trans-
fected with a yy1 or gata3 expression vector. Cell lysates were immuno-
precipitated with anti-GATA3, anti-YY1, or a control IgG antibody, and then
immunoblotted with anti-YY1 or anti-GATA3 antibody as indicated. (B) In
vitro–differentiated Th1 or Th2 cells were treated with rabbit anti-YY1 and
mouse anti-GATA3 antibodies, and then with Alexa Flour 647–conjugated
anti-mouse IgG or Alexa Flour 546–conjugated anti-rabbit IgG. DNA was
counterstained with DAPI. Images were recorded with fluorescence micros-
copy. (C) In vitro–differentiated Th1 or Th2 cells were treated with anti-YY1
and anti-GATA3 antibodies, and then in situ proximity ligation assay was

























































































































Fig. 4. YY1 recruits GATA3 to Th2 cytokine locus. (A) Reduced GATA3
binding to the Th2 cytokine locus in YY1 KD Th2 cells. Naive CD4 T cells were
isolated from control (pSico-YY1) or YY1 KD [pSico-YY1(CD4-Cre)] mice, and
differentiated under a Th1 or Th2 polarizing condition. GATA3 binding to
regulatory elements in the Th2 cytokine locus was measured by ChIP using
an anti-GATA3 antibody. Statistical difference was analyzed by Student
t test. n = 3. *P < 0.05. Data are representative of three independent
experiments with similar results. (B) YY1 binding to the Th2 cytokine locus
precedes GATA3 binding. The kinetics of YY1 and GATA3 binding to the Th2
cytokine locus at various time points after Th2 stimulation. y axis shows
relative binding compared with the initial binding at time 0 h (naive CD4 T
cells). Data are representative of three independent experiments with sim-
ilar results.















































In this study, we examined the role of Th2 LCR-binding tran-
scription factor YY1 in Th2 cell differentiation. Reduction
of YY1 resulted in the decreased expression of Th2 cytokine
genes, repressed chromatin conformation, decreased intra-
chromosomal interactions, and resistance in an animal model of
asthma. YY1 physically associated with GATA3 and bound to
promoters of Th2 cytokine genes before GATA3. These results
strongly suggest that YY1 is a critical transcription factor for dif-
ferentiation of Th2 cells.
Our results showed that YY1 is necessary for Th2 cytokine ex-
pression, chromatin remodeling, and intrachromosomal inter-
actions in the Th2 cytokine locus. YY1 is a transcription factor that
acts either as an activator or repressor depending on the promoter
context (41–43). YY1 interacts with a number of factors including
basal and tissue-specific transcription factors, coactivators, and
corepressors (41–43). In addition, YY1 has pleiotropic effects
on many different cellular processes such as cell growth and dif-
ferentiation, apoptosis, development, and tumorigenesis (41–43).
Likewise, YY1 seems to exert several different functions in Th2 cell
differentiation. The first function of YY1 in Th2 differentiation is
that it may be a necessary factor in chromatin modification. Our
data showed that YY1 KD resulted in more repressed chromatin
states with lower levels ofH3K4-me1 or 3 and higher levels ofDNA
methylation. YY1 is well known to interact with several chromatin
modification factors such as histone acetyltransferases, histone
deacetylases, histone methyltransferase, and chromatin remodel-
ing factor INO80 (41-45). YY1 also has been shown to function in
the formation of heterochromatin and double-strand breaks (46).
Thus, it is possible that YY1 interacts with some of these factors to
modify or remodel chromatin status in the Th2 cytokine locus; it
will be interesting to elucidate the detailed mechanism of chro-
matin modification and the role of YY1 in this process.
The second function of YY1 is that it may mediate the chro-
mosomal interactions between the Th2 LCR and the promoters
of Th2 cytokine genes in the Th2 cytokine locus. This possibility is
supported by a previous report that YY1 is critical to “locus
contraction” in the process of IgH locus rearrangement during
B-cell differentiation (47). Locus contraction is a phenomenon in
which chromosomal regions contract resulting from formation of
chromatin loops for long-range gene rearrangement at the Ig
gene loci. Locus contraction may be a specific process for Ig or
TCR gene loci; however, the underlying mechanism of chromo-
somal looping may be similar to intrachromosomal interactions at
the β-globin and Th2 cytokine loci. Thus, YY1 may have a critical
role in the chromosomal looping process, which our data support.
It will be interesting to determine how YY1 mediates chromo-
somal looping. One possibility is that YY1 may interact with the
nuclear matrix in the formation of chromosomal loops. YY1 has
been shown to associate with a nuclear matrix (48, 49). It has also
been shown that intrachromosomal interactions in the Th2 cy-
tokine locus are mediated by SATB1 (36), which is a matrix-
binding protein.
The third function of YY1 is that it may recruit GATA3 in the
Th2 cytokine locus. Our results showed that YY1 and GATA3
coimmunoprecipitated in cells overexpressing these proteins,
and these two proteins were colocalized in Th2 cells, suggesting
physical association between them. GATA3 binding to the Th2
cytokine locus is greatly reduced in YY1 KD Th2 cells, sug-
gesting that YY1 is required for the binding. Protein-binding
kinetics shows that YY1 bound to the Th2 cytokine locus about
12–24 h before GATA3 binding. These data suggest that YY1
may directly recruit GATA3 to the Th2 cytokine locus after
initiation of Th2 differentiation. It is well known that YY1
recruits corepressors and coactivators to DNA (YY1 binding
site), and it is one of the suggested mechanisms for YY1 function
(41–43). Corepressors and coactivators do not have sequence-
specific DNA binding domains, so it is reasonable to speculate
that they require other transcription factors to be recruited to
DNA. It is not clear why GATA3 requires another protein to be
recruited to DNA, because GATA3 contains its own DNA-
binding domain. One possibility is that GATA3 may bind to its
cognate DNA binding sites, but this binding may be synergistically
increased by cooperative binding ofYY1.Another possibility is that
YY1 may provide a platform for facilitated binding of GATA3.
As mentioned previously in the first and second suggested YY1
functions, YY1 may initiate chromatin remodeling by recruiting
coactivators to be accessible for GATA3 binding or it may provide
a platform in a nuclear matrix for GATA3 binding. Further study
will be needed to elucidate the detailed mechanism of protein re-
cruitment in the regulatory elements.
A previous study by Guo et al. has shown that YY1 activates il4
promoter activity (50), suggesting direct activation of IL4 pro-
moter is another function of YY1. The same group has also shown
that YY1 heterozygote mice, which express a low level of YY1,
manifest reduced symptoms of experimental allergic asthma (51).
Our data using CD4-specific YY1 KD mice are consistent with
their result and further specifies the role of CD4 T-cell–driven
YY1 in an experimental allergic response.
The binding sites of YY1 beforeGATA3were confined to some,
but not all, regulatory elements (Fig. 4A). The reason for this is not
clear. One possibility is that this confinedYY1 bindingmay initiate
chromatin remodeling at the whole Th2 locus by sequential re-
cruitment of the GATA3 or chromatin-modifying factors, and this
initiation process may not require binding of YY1 to all regulatory
elements. It is also not clear why YY1 binds to Th2 locus in a Th2-
specific manner. One possible explanation is differential expres-
sion of YY1 between Th1 and Th2 cells. Th2 cells express a higher,
although modest, amount of YY1 than does Th1 cells after TCR-
stimulation (Fig. 1 B and C). Another possibility, although not






























































































Th1 Th1 Th2Th2Th2Th2 Th1Th1
ve ve yy1yy1

















Th1 Th1 Th2Th2Th2Th2 Th1Th1
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control YY1 KD
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ve ve gata3gata3
control YY1 KD
Th1 Th1 Th2Th2Th2Th2 Th1Th1
ve ve gata3gata3
control YY1 KD
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GATA3 f/f GATA3 f/f Cre
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ve ve yy1yy1
GATA3 f/f GATA3 f/f Cre
Fig. 5. YY1 is required but not
sufficient for Th2 cytokine expres-
sion. Naive CD4 T cells from control
or YY1 KD mice were transduced
with control or gata3 retroviral vec-
tor (A), or naive CD4 T cells from
GATA3f//fl mice were transduced
with control, yy1, or yy1+Cre ret-
roviral vectors (B). Then, cells were
induced to differentiate into Th1
or Th2 cells. Total RNAwas isolated
from the cells, andgene expression
was measured by quantitative RT-
PCR. Data were normalized by
the amount of hprt. Data are rep-
resentative of three independent
experiments with similar results.






































mutually exclusive, is that Th2-specific binding ofYY1 toTh2 locus
may occur by recognizing cell type–specific features such as Th2-
specific factors, signaling molecules, or chromatin status or by
cooperating with them, although we do not have direct evidence
for that. Cell type–specific binding of YY1 to a given promoter or
enhancer has been shown in many other studies (41-43).
In conclusion, our study strongly suggests that YY1 is a neces-
sary and critical factor for Th2 cell differentiation by cooperating
with GATA3 and by impacting chromatin modification and chro-
mosomal interactions. This study helps elucidate the fundamental
process of cell differentiation of T-helper cells, information that
may prove useful in the development of a therapeutic strategy for
curing Th2-mediated diseases. Detailed mechanisms of chromatin
modification and chromosomal interactions mediated by YY1
await elucidation in further study.
Materials and Methods
We used many molecular and cell biological methods to analyze the
function of YY1 in Th2 cell differentiation. We also used WT, YY1 KD,
GATA3flox/-, CD4-Cre transgenic, and RHS7-deficient mice for the experi-
ment. The full information is listed in the SI Materials and Methods.
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